McGuire Investment Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,546
| Closed | -$113K | – | 114 |
|
|
2025
Q1 | $113K | Sell |
3,546
-10,981
| -76% | -$349K | 0.02% | 111 |
|
|
2024
Q4 | $564K | Buy |
14,527
+485
| +3% | +$18.8K | 0.08% | 78 |
|
|
2024
Q3 | $632K | Sell |
14,042
-420
| -3% | -$18.9K | 0.09% | 78 |
|
|
2024
Q2 | $604K | Sell |
14,462
-201
| -1% | -$8.39K | 0.09% | 77 |
|
|
2024
Q1 | $667K | Buy |
14,663
+924
| +7% | +$42.1K | 0.1% | 78 |
|
|
2023
Q4 | $635K | Sell |
13,739
-2,296
| -14% | -$106K | 0.11% | 75 |
|
|
2023
Q3 | $652K | Sell |
16,035
-1,955
| -11% | -$79.5K | 0.13% | 71 |
|
|
2023
Q2 | $872K | Sell |
17,990
-5,080
| -22% | -$246K | 0.16% | 68 |
|
|
2023
Q1 | $1.14M | Sell |
23,070
-39,479
| -63% | -$1.95M | 0.23% | 63 |
|
|
2022
Q4 | $3.16M | Sell |
62,549
-66,509
| -52% | -$3.37M | 0.68% | 42 |
|
|
2022
Q3 | $6.48M | Sell |
129,058
-2,414
| -2% | -$121K | 1.48% | 29 |
|
|
2022
Q2 | $6.43M | Buy |
131,472
+475
| +0.4% | +$23.2K | 1.38% | 30 |
|
|
2022
Q1 | $7.88M | Buy |
130,997
+23,272
| +22% | +$1.4M | 1.44% | 29 |
|
|
2021
Q4 | $8.55M | Buy |
107,725
+22,268
| +26% | +$1.77M | 1.41% | 28 |
|
|
2021
Q3 | $7.57M | Buy |
85,457
+18,981
| +29% | +$1.68M | 1.42% | 31 |
|
|
2021
Q2 | $6.62M | Sell |
66,476
-307
| -0.5% | -$30.6K | 1.26% | 34 |
|
|
2021
Q1 | $6.01M | Buy |
+66,783
| New | +$6.01M | 1.27% | 33 |
|